Our research is focused on: 1. Identifying genetic markers for chemotherapy induced adverse drug reactions 2. the toxicity of new psychoactive substances & how to use post-mortem metabolomics. We develop prediction models using massive parallel sequencing, single cell RNASeq & high resolution chromatin conformation capture and bioinformatics with large clinical cohorts. In forensics, we develop new techniques using the CBRS platform for neuropharmacology as well as post-mortem metabolomics.
Henrik Green
Linköping University
Key Publications
Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5‐HT2A receptor
British Journal of Pharmacology, 2026
Postmortem metabolomics as a window into the agonal phase of death: a comparison between opioid intoxications and hangings
International Journal of Legal Medicine, 2026
Anomaly detection as a tool for identifying cases of interest in postmortem toxicology
Scientific Reports, 2026
5‐HT2A receptor agonism by tert‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence
British Journal of Pharmacology, 2026
Development and analytical validation of a targeted short‐read next generation sequencing‐based pharmacogenetic panel for comprehensive variant detection
British Journal of Pharmacology, 2026